↓ Skip to main content

Cochrane Database of Systematic Reviews

Long-acting beta2-agonist in addition to tiotropium versus either tiotropium or long-acting beta2-agonist alone for chronic obstructive pulmonary disease

Overview of attention for article published in this source, April 2012
Altmetric Badge

Mentioned by

policy
1 policy source
twitter
3 X users
wikipedia
8 Wikipedia pages

Citations

dimensions_citation
69 Dimensions

Readers on

mendeley
92 Mendeley
citeulike
1 CiteULike
Title
Long-acting beta<sub>2</sub>-agonist in addition to tiotropium versus either tiotropium or long-acting beta<sub>2</sub>-agonist alone for chronic obstructive pulmonary disease
Published by
John Wiley & Sons, Ltd, April 2012
DOI 10.1002/14651858.cd008989.pub2
Pubmed ID
Authors

Karner, Charlotta, Cates, Christopher J

Abstract

Long-acting bronchodilators comprising long-acting beta(2)-agonists and the anticholinergic agent tiotropium are commonly used for managing persistent symptoms of chronic obstructive pulmonary disease. Combining these treatments, which have different mechanisms of action, may be more effective than the individual components. However, the benefits and risks of combining tiotropium and long-acting beta(2)-agonists for the treatment of chronic obstructive pulmonary (COPD) disease are unclear.

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 92 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Chile 1 1%
Colombia 1 1%
Unknown 90 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 20 22%
Researcher 13 14%
Other 12 13%
Student > Bachelor 10 11%
Student > Postgraduate 7 8%
Other 16 17%
Unknown 14 15%
Readers by discipline Count As %
Medicine and Dentistry 46 50%
Nursing and Health Professions 9 10%
Pharmacology, Toxicology and Pharmaceutical Science 8 9%
Biochemistry, Genetics and Molecular Biology 3 3%
Agricultural and Biological Sciences 2 2%
Other 7 8%
Unknown 17 18%